Endothelin-1 acts as a pro-inflammatory cytokine in the heart, with specific downstream pathways implicated in the pathophysiology of myocarditis and inflammatory cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Endothelin-1 pathways merit exploration in inflammatory cardiomyopathy; leaves open therapeutic targeting pending prospective validation.
Endothelin-1 has emerged as an important participant in the pathophysiology of a variety of cardiovascular diseases, where it may act on endocrine, paracrine and autocrine bases. Here we review its regulated biosynthesis, receptor-mediated signaling, and functional consequences in the heart, with particular emphasis on cardiac development and disease. Exploring published data employing molecular genetic mouse models of endothelin dysregulation, we highlight its heretofore underappreciated role as a pro-inflammatory cytokine. We also present novel micro-array data from one such mouse model, which implicate the specific downstream pathways that may mediate endothelin-1's effects.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: